Kazia Therapeutics Ltd CEO and MD highlights 2021 progress with focus on providing treatment for diagnosed glioblastoma proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: The scientists found elevated levels of cell drinking, or macropinocytosis (green) in the stromal cells exposed to a low-nutrient environment (right), compared to normal nutrient levels that surround healthy tissue. view more
Credit: Sanford Burnham Prebys Medical Discovery Institute
Scientists at Sanford Burnham Prebys Medical Discovery Institute demonstrated for the first time that blocking cell drinking, or macropinocytosis, in the thick tissue surrounding a pancreatic tumor slowed tumor growth providing more evidence that macropinocytosis is a driver of pancreatic cancer growth and is an important therapeutic target. The study was published in Now that we know that macropinocytosis is revved up in both pancreatic cancer cells and the surrounding fibrotic tissue, blocking the process might provide a double whammy to pancreatic tumors, says Cosimo Commisso, Ph.D., associate professor and co-director of the Cell and Molecular Biology of C
BREITBART
18 Mar 2021
Months after mammograms, colonoscopies and other routine cancer screenings were suspended because of the pandemic, researchers are studying the impact
Researchers study impact of pandemic cancer screening pauseBy MARILYNN MARCHIONEAP Chief Medical WriterThe Associated Press
John Abraham’s colonoscopy was postponed for several months because of the pandemic. When he finally got it, doctors found a growth too big to be removed safely during the scope exam. He had to wait several weeks for surgery, then several more to learn it had not yet turned cancerous.
“I absolutely wonder if I had gotten screened when I was supposed to have, if this would have been different” and surgery could have been avoided, said Abraham, a mortgage banker in Peoria, Illinois.
Cancer mutations insight could boost detection and personalize treatments eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
NANOBIOTIX Reports Full Year 2020 Financial Results and Highlights Operational Progress
Substantial progress in priority development pathway in head and neck cancer with clinical registration plan announced, Fast Track designation granted by US Food and Drug Administration, and new data from phase I dose expansion showing 83% objective response rate in primary lesion.
First clinical data reported phase I immuno-oncology trial showing conversion of anti-PD-1 non-responders to responders.
Extended global capital markets presence with a successful Nasdaq IPO that provided gross proceeds of €93.5 million ($113.3 million).
Cash, cash equivalents, and short-term investments were €119.2 million at December 31, 2020, supporting robust development plans into the second quarter of 2023.